Ophidion Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Ophidion Inc. - overview
Location
Bethlehem, PA, US
Primary Industry
Biotechnology
About
Based in Pennsylvania, US, Ophidion Inc. operates as an early-stage central nervous system (CNS) biopharmaceutical company focused on developing a pipeline to deliver gene silencing therapies to treat neurodegenerative diseases. In October 2022, Ophidion Inc. raised USD 0.
75 million in seed funding led by Robin Hood Ventures, with participation from Ben Franklin Technology Partners, Delaware Crossing Investor Group, Gaingels Syndicate, and Viva Incubator Investment Management Limited. As of December 2022, the company owns seven issued patents, four in the US, two in Japan, and one in Europe, and is led by its CEO Yacoub Habib. Ophidion Inc. develops a platform technology that acts as a Trojan horse strategy to exploit an endogenous receptor-mediated transport system to deliver various therapeutic cargos, including biologics, into the brain for the treatment of various CNS disorders and brain malignancies including Huntington’s disease (HD), diseases of cognitive impairment (e.
g. Alzheimer’s disease, Parkinson’s disease), and Parkinson’s disease, Alzheimer’s disease, Frontotemporal Dementia, ALS, and Glioblastoma Multiforme. In addition, the company runs an analgesia program that involves a non-opioid mechanism of action and an anti-anxiety program coupled with genomic testing to treat various difficult-to-treat anxiety disorders.
Current Investors
Ben Franklin Technology Partners, Robin Hood Ventures, Delaware Crossing Investor Group
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development
Website
www.ophidion.com/
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Ophidion Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.